Open AccessCycloserine induced delirium during treatment of multi-drug resistant tuberculosis (MDR-TB)
Author(s) -
Gayatri Saraf,
J.S. Akshata,
Seby Kuruthukulangara,
Harish Thippeswamy,
Senthil Kumar Reddy,
Shashidhar Buggi,
Santosh K. Chaturvedi
Publication year - 2015
Publication title -
egyptian journal of chest diseases and tuberculosis/egyptian journal of chest diseases and tuberculosis
Language(s) - English
Resource type - Journals
eISSN - 2090-9950
pISSN - 0422-7638
DOI - 10.1016/j.ejcdt.2014.11.032
Subject(s) - cycloserine , delirium , medicine , tuberculosis , drug , intensive care medicine , pharmacology , pathology
ObjectiveTo report about delirium related to Cycloserine.MethodSystematic assessment and management of a patient who developed delirium during the course of treatment for MDR-TB.ResultsAn association was found with the use of Cycloserine and development of delirium. The management of this case is described.ConclusionPatients with MDR-TB receiving Cycloserine should be closely monitored for neuropsychiatric side effects for early recognition and treatment